Insulin Di Arg
Alternative Names: DiarginylinsulinLatest Information Update: 25 Aug 1995
At a glance
- Originator Aventis
- Class Amino acids; Antihyperglycaemics; Insulins
- Mechanism of Action Phosphokinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 14 Jul 1995 A clinical study has been added to the pharmacokinetics section